Clinical Trials

Novaerus technology has been shown to safely and effectively reduce bacteria, viruses, VOCs, and particulate matter in dozens of independent laboratory tests. In case studies and clinical trials, our products have been demonstrated to reduce infections and improve wellbeing in real-world settings. 

Evaluation of the Novaerus Technology in a Dialysis Centre

Novaerus reduces VOCs by 93%, airborne bacteria by 87% and moulds by 67%.

Evaluation of the Novaerus Technology in an Emergency Hospital

Novaerus shown to reduce airborne Staphylococcus by 100%, airborne bacteria by 89% and airborne fungi by 87%.

Evaluation of the Novaerus Technology in Hospital Wards

Novaerus reduces staff sickness, ward odours, infections and antibiotic use. Wards with Novaerus have had no outbreaks of MRSA, C. diff, influenza, or norovirus since installation.

Evaluation of the Novaerus Technology in a Hospital

Novaerus reduces environmental surface MRSA by 97% and reduces environmental surface TVC and environmental air MRSA at the Royal Free Hospital, London.

Evaluation of the Novaerus Technology in an Infectious Disease Hospital

Novaerus shown to reduce airborne bacteria and fungi 96% at the “Dr V. Babes” Hospital of Infectious and Tropical Diseases in Bucharest, Romania.

Evaluation of the Novaerus Technology in Intensive Care

Novaerus plasma technology shown to significantly reduce number of microorganisms at Brothers Hospitallers of Saint John of God Hospital in Łódź, Poland.

Evaluation of the Novaerus Technology in a Nephrology Clinic

Novaerus shown to reduce bacterial loads on high surfaces and window sills as well as reduce overall infection rates by 23% compared to increase of infection rates by 35% in control section at Rigshospitalet in Copenhagen, Denmark.

Evaluation of the Novaerus Technology in an Ophthalmology Operating Room

Novaerus reduces bacterial colony count in both the rooms that were being used and those that were empty at Ain Shams University in Cairo, Egypt.

Evaluation of the Novaerus Technology in a Paediatric Department

Novaerus devices effectively reduce the number of airborne pathogens by 61% in the admission room of the Paediatric Department and by 19% in the Clinic of Pulmonology/Tuberculosis and Pulmonary Diseases at Międzyrzecz Hospital in Międzyrzecz, Poland.

Evaluation of the Novaerus Technology in a Pulmonology Department

Novaerus reduces CFU rates by 82% and fungi count by 93% after 2 months of operation at the Uzsoki Hospital in Budapest, Hungary.

Evaluation of the Novaerus Technology in a Specialised Hospital

Novaerus devices significantly reduce number of microorganisms as well as eliminate unwanted odours at Specialised Hospital in Chorzów, Poland.